NADMED
Helsinki
About NADMED
The NADMED test was developed by one of the world's foremost experts on NAD metabolism in humans. NADMED's metabolite extraction system is the only method for measuring all four NADs and glutathione.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.9M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2024)
- Website: nadmed.com
- Phone: +358 44-242-3751
Industries & Categories
Biotechnology, Product Research
Social Profiles
Canonical: https://fsome.com/organization/nadmed-31375 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.